D0633
7-(2,3-Dihydroxypropyl)theophylline
PDE inhibitor, powder
Synonym(s):
7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione, Diprophylline, Dyphylline
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C10H14N4O4
CAS Number:
Molecular Weight:
254.24
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
41106305
EC Number:
207-526-1
MDL number:
Beilstein/REAXYS Number:
284563
Form:
powder
Product Name
7-(2,3-Dihydroxypropyl)theophylline,
form
powder
mp
161-162 °C (lit.)
SMILES string
CN1C(=O)N(C)c2ncn(CC(O)CO)c2C1=O
InChI
1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3
InChI key
KSCFJBIXMNOVSH-UHFFFAOYSA-N
Gene Information
human ... PDE3A(5139), PDE4A(5141), PDE4B(5142), PDE4C(5143), PDE4D(5144)
Biochem/physiol Actions
7-(2,3-Dihydroxypropyl)theophylline is also called as dyphylline. Dyphylline serves as a bronchodilator and aids in better air flow through the lungs. It reduces the symptoms of chronic lung disorder such as asthma and bronchitis.
Features and Benefits
This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
Storage Class
11 - Combustible Solids
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
S H Neau et al.
International journal of pharmaceutics, 179(1), 97-105 (1999-03-04)
Release data from ethylcellulose (EC) matrix tablets was analyzed to determine which release equation provides the best fit to the data and to observe the effect of drug solubility on the release mechanism(s). Tablets were prepared by direct compression of
Judyta Cielecka-Piontek et al.
Journal of pharmaceutical and biomedical analysis, 46(1), 52-57 (2007-10-16)
The following first-order rate constants of the degradation of ertapenem in INVANZ and meropenem in MERONEM were determined: (a) in dry air at 363, 373, 378, 383, 388, 393 K; (b) at increased relative air humidity (76.4% RH) at 313
F Siepmann et al.
Journal of controlled release : official journal of the Controlled Release Society, 141(2), 216-222 (2009-09-10)
Kollidon SR-based matrix tablets containing various amounts of diprophylline were prepared and thoroughly characterized in vitro. This includes drug release measurements in 0.1M HCl and phosphate buffer pH 7.4, monitoring of changes in the tablet's height and diameter, morphology as